Search

everythinglearnresearchcommunity

for

Search:↓

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

COVID-19 has widely affected health, various industries, and the economy, but also led to more remote work and less pollution.

SARS-CoV-2 might infect and multiply in skin tissue, possibly aiding in its transmission.

Organoid technology is advancing and entering commercial use, with applications in disease modeling, drug development, and personalized medicine.

Women with PCOS may have a higher risk of severe COVID-19 due to hormonal imbalances and vitamin D deficiency.

Retinoic acid helps change skin cells and is important for skin development and hair growth.

COVID-19 can cause hair loss, and managing it involves counseling, diet changes, and treatments.

The androgen receptor's shape-changing ability helps it function but can lead to cancer treatment resistance.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

Treating post-COVID hair loss leads to full recovery, while not treating it often results in ongoing symptoms.

Men with early balding showed higher levels of certain genes linked to hair loss and possibly prostate cancer.

About 61% of women who had COVID-19 experienced hair loss afterward.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

New understanding and treatments for hair loss are improving, but more research is needed.

COVID-19 can cause long-term skin problems and has changed how skin doctors work.

5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

Many people experienced hair loss after having COVID-19, with the worst cases in hospitalized patients, and some saw hair regrowth within six months.

COVID-19 may worsen hair loss in people with a certain type of scarring alopecia, but early treatment can help improve symptoms and hair regrowth.

COVID-19 can cause temporary hair loss due to stress and inflammation.

COVID-19 can cause skin issues like rashes and hair loss, which may last even after recovery.

COVID-19 may worsen hair loss, and Nourkrin® could be a safe treatment option, but more research is needed.

COVID-19 can cause skin symptoms that might help spot the virus early, and treatments for it can also affect the skin.

COVID-19 may worsen hair loss, but treatments like minoxidil can help.

Some vitamins and minerals like vitamin D and iron can help with certain types of hair loss, but more research is needed for others.

Correcting nutrient deficiencies may help with hair loss, but the benefits of supplements without a deficiency are uncertain and could be harmful.

Cysteine helps maintain keratin production in skin cells even when iron is low.

The conclusion suggests a possible link between iron levels and hair health in women, recommending further research on iron supplementation for hair loss.

Microneedle made of iron oxide and PVA helps hair regrowth in alopecia treatment.

UVB radiation changes the levels of certain microRNAs in skin cells, which may affect cell survival and hair growth.